Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 4, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

FAS-less allogeneic CAR T cells

Keith P Eidell¹, Michael T Hemann^2,3

¹The Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.

Nature Biomedical Engineering

|December 20, 2024

Summary

No abstract available in PubMed .

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

Related Experiment Videos

Last Updated: Jun 4, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A functional map of CDK-drug interactions at single amino acid resolution.

bioRxiv : the preprint server for biology·2025

Same author

Leveraging platinum-protein interactions to overcome chemoresistance.

Nature communications·2025

Same author

Sensitization of cancer cells to DNA-damaging agents by expression of the REV1 C-terminal domain: Implications for chemotherapy.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

Multiplexed <i>in vivo</i> base editing identifies functional gene-variant-context interactions.

bioRxiv : the preprint server for biology·2025

Same author

Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool.

Science advances·2024

Same author

Leukemia circulation kinetics revealed through blood exchange method.

Communications biology·2024

Same journal

Rewiring tumour mechanosensing to overcome CAR T cell resistance.

Nature biomedical engineering·2026

Same journal

Identifying and reprogramming softness-driven cancer stem-like cells overcomes CAR-T cell resistance in solid tumours.

Nature biomedical engineering·2026

Same journal

CD98hc-targeted antibody shuttles for central nervous system delivery with broad cross-species reactivity.

Nature biomedical engineering·2026

Same journal

AI-orchestrated design-build-test-learn is the future of mammalian biodesign.

Nature biomedical engineering·2026

Same journal

Lab-on-a-disc biosensing platform for folate level quantification.

Nature biomedical engineering·2026

Same journal

BoneCoT: multicentre validation of a whole-body skeleton foundation model for bone metastases guided by clinician-derived chain of thought.

Nature biomedical engineering·2026

See all related articles